News release
From:
Physical fitness of transgender and cisgender women is comparable, current evidence suggests
Despite greater muscle mass of transgender women 1-3 years after hormone therapy
Evidence is of variable quality, but doesn’t back inherent athletic advantage theories
Transgender women might have more muscle mass than cisgender women 1 to 3 years after hormone therapy, but their physical fitness is comparable, finds a pooled data analysis of the thaavailable evidence, published online in the British Journal of Sports Medicine.
While the current body of evidence is of variable quality, and doesn’t look at the potential for any advantage at the elite athlete level, it doesn’t back up prevailing theories about the inherent athletic advantage of transgender women, conclude the researchers.
Whether transgender women should be allowed to compete in female sports, and under what conditions, remains hotly contested, explain the researchers. Policies advocating blanket bans on transgender women’s participation in female sports often cite residual advantages from previous testosterone exposure, they add.
While previously published studies suggest that hormone therapy may alter body composition in transgender people, the evidence on their functional performance and physical advantage is mixed, they point out.
In pursuit of clarification, the researchers scoured research databases for studies comparing the body composition or physical fitness of transgender people before and after hormone therapy with that of cisgender people.
In all, 52 studies involving 6485 people (2943 transgender women, 2309 transgender men, 568 cisgender women and 665 cisgender men; age range 14 to 41) were eligible for review.
The studies varied in design and methodology. Some 45 focused on adults; 7 involved teenagers. Only 16 included any form of physical activity assessment, and most didn’t compare transgender athletes with cisgender athletes. And only 7 adjusted for potentially influential factors, including body composition, hormone levels, and nutrient intake.
In all, 22 studies were prospective; 9 were retrospective; 17 were cross-sectional (observational studies): 3 were randomised controlled trials; and 1 was a quasi-experimental study.
Pooled data analysis of the findings from 46 of the studies showed that transgender women’s body composition differs from that of both cisgender men and cisgender women.
Transgender women have significantly greater amounts of body fat than cisgender men but levels comparable to those of cisgender women.
And while transgender women had more lean mass, a proxy for muscle, there were no observable differences in upper or lower body strength, or in a key measure of cardiorespiratory fitness—maximal oxygen consumption (VO₂ max)—between them and cisgender women.
Transgender women’s upper and lower body strength and their VO₂ max were also all much lower than they were in cisgender men.
While hormone therapy was associated with higher amounts of body fat and lower
amounts of muscle and less upper body strength 1–3 years after the start of treatment
in transgender women, transgender men had less fat, more muscle, and greater strength after hormone therapy.
The researchers acknowledge various limitations to their findings, including short study length and an absence of information on elite athletes. Few studies assessed specific outcomes or the impact of puberty suppression.
And reporting on, and adjustment for, potentially influential factors, such as training history, diet, baseline fitness, physical activity and body composition or previous hormone therapy, were inconsistent. Few studies included a broad spectrum of ages, types of sport, and competitive levels.
Nevertheless, the findings prompt the researchers to conclude: “The convergence of transgender women’s functional performance with cisgender women, particularly in strength and aerobic capacity, challenges assumptions about inherent athletic advantages derived solely from [gender affirming hormone therapy] or residual lean mass differences.”
They add: “Although the current data do not justify blanket bans, critical gaps in literature were found, notably the under-representation of transgender athletes who may retain more ‘muscle memory’.
“Ideally, to resolve speculation, future long-term, longitudinal studies should prioritise performance-specific metrics in transgender athletes. However, one should be aware of the scarce number of transgender athletes, particularly in the elite sport, which complicates the feasibility of conducting powered studies involving high-performance transgender athletes within specific sport disciplines.”
And they emphasise: “Considering this context of imperfect evidence and despite the methodological challenges, continued research into physiological as well as psychosocial trajectories among transgender athletes with diverse demographics and clinical characteristics remains essential for developing equitable frameworks that balance justice, inclusion and scientific rigour.”
Expert Reaction
These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.
Research Associate Professor Kim Meredith-Jones is Director of the Bone and Body Composition Research Unit at the University of Otago
“I am not a clinical expert in gender-affirming hormone treatments. My perspective comes from experience measuring body composition, and some very cursory clinical experience working with adolescent transgender populations. With that context in mind, these findings are interesting, but they need to be interpreted carefully.
"Although this review included a large number of transgender participants overall, most were adults. This means the results cannot tell us what happens for young people who use puberty blockers or begin medical transition during adolescence. That remains an important evidence gap.
"The finding that transgender women had higher lean mass than cisgender women, but did not differ in strength or aerobic fitness, should also be interpreted with caution. These outcomes were often measured in different groups of participants, rather than in the same individuals. In addition, only a small number of studies included fitness data, and strength testing was carried out in far fewer participants than body composition measurements. This makes it difficult to draw firm conclusions about how muscle mass relates to physical performance.
"Finally, the studies included in the review varied widely in methods, hormone treatment duration, and measurement techniques. While the results add useful information to an evolving area of research, they should not be seen as definitive and highlight the need for better-designed, long-term studies that measure both body composition and physical performance in the same participants.”
Connor Macdonald is a Researcher and Lecturer at Adelaide University
"As the authors of this study have stated, those who advocate for blanket bans of transgender women from participation in sport hinge their argument on transgender women having inherent physical advantages over cisgender women. These bans are most obviously seen in the US at the federal level, and in Canada at the provincial level in Alberta. As has been recognised for some time, the science around inherent sport advantage is inconclusive, yet those who have pushed campaigns against inclusion have often relied on “common-sense” arguments that essentialise transgender and cisgender women. This study challenges not only the taken-for-granted views that transgender women retain sport-specific physical advantages over cisgender women, but also the social construction of transgender women and men.
While the authors conclude with a call for further study and developing nuanced and context-dependent inclusion policies, I think there needs to be further conversation around the social constructions of sport and gender. Sport’s history as a domain exclusively for men has produced discrepancies in all women’s equitable access and participation in sport. And while these historical implications are constantly contested, there are still further opportunities to change how sport can be practiced, and that starts with inclusion."
Associate Professor Phoebe Toups Dugas is an Associate Professor of Human-Centred Computing in the Faculty of Information Technology at Monash University and a member of the Exertion Games Lab
"Physical characteristics impact sports performance. This affects players' chance at a fair go and their ability to socially enjoy their bodies. It affects how interesting a competition is. Many sports segregate based on sex, assuming that women and men have knowable inherent characteristics that impact performance – it turns out they're neither knowable nor predictably affect performance. This paper points out that:
- identifying the impacts of hormones and sexual development on athletic performance is complex and poorly understood – there's not consistent data, nor do physical characteristics predict performance;
- transgender women on hormone therapy become similar to cisgender women in terms of performance, despite retaining lean mass; and
- athletic performance is multifaceted, and attention to gender is not very useful.
Adding in my experience as a transgender woman in dance who studies transgender play – being active and athletic in a trans body is transcendent, and taking such an opportunity away is not backed by science.
We should identify IF and what characteristics matter for a sport, non-invasively test for them, and segregate using them instead. For example, if long arms make one better at a sport, then maybe divisions based on arm length make more sense than gender!"
Professor Ada Cheung is a Professor of Endocrinology at The University of Melbourne
"Blanket bans on transgender women in sport are not supported by the best available evidence. This large new review, combining data from more than 6,000 people across 52 studies, shows that after gender-affirming hormone therapy, transgender women are no different from cisgender women in body fat percentage, muscle percentage, strength, or cardiorespiratory fitness. While trans women are, on average, taller and may retain slightly more absolute muscle, this does not translate into meaningful advantages in performance, such as strength or aerobic capacity
What we still do not know precisely is how long these changes take to fully converge after starting hormone therapy, which is why sport needs evidence-based, sport-specific guidelines rather than one-size-fits-all rules.
The idea that male puberty creates permanent athletic advantage is not supported by current data if someone is using gender affirming hormone therapy. Restrictive bans also harm cisgender girls and women by policing bodies and reinforcing narrow ideas about how women are supposed to look or perform. Fairness and inclusion can coexist.
Instead of blanket bans, we need eligibility criteria for elite sport, and we should focus on the real work of supporting women’s sport: improving visibility and pay, reducing sexual harassment and assault, expanding access to facilities and coaching, and ensuring fair media coverage. These changes actually advance equity, while building sporting systems that are safe, inclusive, and grounded in evidence."
Antonio Guillamón Fernández, Professor emeritus of Psychobiology, Spain, said:
"The work by Sieczkowska and colleagues, to be published in the British Journal of Sports Medicine (part of the BMJ group), consists of a systematic review followed by a meta-analysis of transgender people who underwent gender-affirming hormone treatment for at least three years, comparing them with cisgender men and women using various measures including fat-free body mass and upper and lower limb strength.
"In my opinion, the study has two significant flaws, which are only detectable after a thorough and careful reading. Firstly, the study presents a significant discrepancy between the conclusions drawn in the abstract and the limitations acknowledged in the discussion, which is worth highlighting. In the abstract, the authors state that their results ‘do not support theories of inherent athletic advantages in trans women versus cis women’.
"This formulation suggests to the reader a strong and general conclusion, with clear implications for public debate. However, in the discussion, the authors themselves explicitly acknowledge that the lean mass and physical performance data do not necessarily come from the same cohorts or study designs, which prevents direct correlations from being established between muscle mass and strength or functional performance.
"This acknowledgement invalidates any robust inference about the existence or absence of athletic advantages. From a methodological point of view, the evidence presented does not allow for conclusions in either direction. What the data show is, at most, an absence of detectable differences in certain performance metrics in the short and medium term, but not a refutation of the hypothesis of inherent athletic advantages.
"The problem is not the quality of the analysis—which is cautious in its discussion—but the rhetorical shift between sections: a strong conclusion in the abstract, which is what most readers and journalists read, and an admission of substantial uncertainty in the body of the article. This type of formulation can lead to simplified or overgeneralised interpretations that are not fully supported by the data.
"In a scientifically complex and socially sensitive field, the distinction between “finding no evidence” and “demonstrating absence of effect” is not a minor nuance, but a basic principle of scientific reasoning. In this case, the study provides relevant information, but does not settle the question that the abstract itself suggests it has resolved.
"Secondly, both the introduction and the discussion lack a developmental perspective that is essential in these cases, specifically the three-phase action of testosterone (during gestation, mini-puberty after birth and from puberty onwards), nor do they mention recent studies on the effects of feminisation treatment (estradiol + cyproterone acetate) on the epigenome".
Gonzalo Correa González, Specialist in Physical Education and Sports Medicine, President of the Spanish Society of Sports Medicine (SEMED-FEMEDE), Head of Medical Services at CD Extremadura, sports doctor at Algeasalud and the Spanish Footballers' Mutual Insurance Company, said:
"In my opinion, the article confirms that transgender athletes have greater muscle mass and, therefore, with proper training, would have a performance advantage over cisgender women. With greater baseline muscle mass and higher testosterone levels until puberty, the body has memory and, with proper stimulation, would be able to develop more functional capacity.
"The study presented takes into account different systems and all types of transgender populations to measure functional capacity. It is not specific to transgender women who participate in sports and, therefore, in my opinion, cannot be extrapolated to professional sports. SEMED-FEMEDE has already issued a statement indicating that, in our opinion, perhaps the fairest solution would be to establish an open or third gender category for competition."
Carlos Alberto Cordente Martínez, Full professor at the Polytechnic University of Madrid in the Faculty of Physical Activity and Sport Sciences – INEF, Spain, said:
"Of course, the research—which can be considered high quality—raises doubts where, apparently, there were none. As it points out, just one to three years after starting hormone treatment, there is a clear convergence in the functional performance of transgender women with that of cisgender women, particularly in strength and aerobic capacity. At the very least, this should lead to a rethinking of certain maximalist positions in the field of competitive sport.
"On the other hand, it is worth highlighting the significant limitations of the study, mainly relating to the small number of transgender athletes in elite sport, which makes it difficult for this type of work to achieve the statistical power necessary to offer categorical results. Therefore, further research is needed.
"The problem, from my point of view—more that of a field technician than a scientist, even though I have participated in research on this topic—lies more on the social than the physiological level. Sports federations are not doing enough to promote policies for the inclusion of transgender people in competition, which deepens the distress these individuals may suffer, with unpredictable consequences for their mental health. Science will take time to resolve this issue; however, there are young people who are missing out on opportunities to compete and feel discriminated against as a result.
"Therefore, beyond the need for further research, I believe it is urgent to explore ways for transgender athletes to participate that do not violate the principle of “physiological equality” that is supposed to govern sport. The solution may not be easy in some sports, but I am convinced that in others it is not so difficult."
Laura Sánchez Amador, Doctor of Health Sciences from the University of Alcalá (UAH), external member of the UAH's Food, Nutrition and Public Health Strategies research group, and lecturer at UNIR and CUNIMAD, Spain, said:
"This article provides an updated summary of physical fitness and body composition in transgender individuals compared to cisgender individuals, integrating data from observational and longitudinal studies that analyse key variables such as fat and lean mass, muscle strength, and maximum oxygen consumption (VO₂max).
"The results show that, in transgender women, relative fat mass (%), upper and lower body strength, and VO₂max are similar to those observed in cisgender women, although absolute lean mass (kg) is higher in some cases. However, this higher lean mass does not seem to translate into significant differences in overall physical fitness, underscoring the importance of distinguishing between body composition and functional performance. Analysis in transgender men shows higher fat mass (before or in the early stages), while muscle mass and strength data remain below those observed in cisgender men.
"The article highlights the role of gender-affirming hormone therapy (GAHT) as a modulator of body composition and VO₂max. In transgender women, longitudinal evidence indicates that hormone therapy is associated, over the first three years, with an increase in fat mass and a reduction in lean mass and strength, especially in the upper body, progressively placing their physiological profiles within the ranges described for cisgender women. However, we must bear in mind that transgender women have also shown lower muscle mass and strength compared to cisgender men. In parallel, transgender men have been observed to have a physiological pattern consistent with the effects of GAHT, with a reduction in fat mass and an increase in lean mass and strength after its initiation.
"The article contributes significantly to clarifying the current state of scientific evidence in a field that requires cautious, evidence-based and contextualised interpretations. We must therefore bear in mind that physical fitness is not a single or static variable, but is determined by the interaction of multiple factors: endocrine, nutritional, training, health, age, etc. Therefore, in order to reach more solid conclusions, further studies are needed that assess these factors together and not in isolation.
"From a methodological point of view, the authors rigorously acknowledge the limitations of the available evidence, pointing out that most studies have low certainty and heterogeneous quality, with small sample sizes and considerable variability in designs, variables assessed and instruments used. This transparency strengthens the interpretative validity of the work and avoids overly generalised conclusions. With these conclusions, the data provided should be subject to review as more robust and methodologically homogeneous longitudinal studies become available."